Antibacterial and Synergistic Activity of Isocryptomerin Isolated from Selaginella tamariscina |
Lee, June-Young
(School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University)
Choi, Yun-Jung (School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University) Woo, Eun-Rhan (College of Pharmacy, Chosun University) Lee, Dong-Gun (School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University) |
1 | Bauer, R. and L. M. Dicks. 2005. Mode of action of lipid IItargeting lantibiotics. Int. J. Food Microbiol. 101: 201-216 DOI ScienceOn |
2 | Cassell, G. H. 1997. Emergent antibiotic resistance: Health risks and economic impact. FEMS Immunol. Med. Microbiol. 18: 271- 274 DOI ScienceOn |
3 | Cookson, B. 2005. Clinical significance of emergence of bacterial antimicrobial resistance in the hospital environment. J. Appl. Microbiol. 99: 989-996 DOI PUBMED ScienceOn |
4 | Jung, H. J. and D. G. Lee. 2008. Synergistic antibacterial effect between silybin and N,N'-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates. J. Microbiol. 46: 462-467 DOI ScienceOn |
5 | Jung, H. J., K.-S. Jeong, and D. G. Lee. 2008. Effective antibacterial action of Tat (47-58) by increased uptake into bacterial cells in the presence of trypsin. J. Microbiol. Biotechnol. 18: 990-996 과학기술학회마을 PUBMED ScienceOn |
6 | Lee, S. J., J. H. Choi, K. H. Son, H. W. Chang, S. S. Kang, and H. P. Kim. 1995. Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. Life Sci. 57: 551-558 DOI ScienceOn |
7 | Paterson, D. L. 2006. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis. 43(Suppl 2): S43-S48 DOI |
8 | Roos, K. L. 2004. Emerging antimicrobial-resistant infections. Arch. Neurol. 61: 1512-1514 DOI PUBMED ScienceOn |
9 | White, D. G., S. Zhao, S. Simjee, D. D. Wagner, and P. F. McDermott. 2002. Antimicrobial resistance of foodborne pathogens. Microbes Infect. 4: 405-412 DOI ScienceOn |
10 | Kim, H. P., H. Park, K. H. Son, H. W. Chang, and S. S. Kang. 2008. Biochemical pharmacology of biflavonoids: Implications for anti-inflammatory action. Arch. Pharm. Res. 31: 265-273 DOI ScienceOn |
11 | Lee, C. W., H. J. Choi, H. S. Kim, D. H. Kim, I. S. Chang, H. T. Moon, S. Y. Lee, W. K. Oh, and E. R. Woo. 2008. Biflavonoids isolated from Selaginella tamariscina regulate the expression of matrix metalloproteinase in human skin fibroblasts. Bioorg. Med. Chem. 16: 732-738 DOI ScienceOn |
12 | Hemaiswarya, S., A. K. Kruthiventi, and M. Doble. 2008. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15: 639-652 DOI ScienceOn |
13 | Cha, H. Y., D. C. Moon, C. H. Choi, J. Y. Oh, Y. S. Jeong, Y. C. Lee, et al. 2005. Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean hospital. J. Clin. Microbiol. 43: 3610-3614 DOI ScienceOn |
14 | Sung, W. S., H. J. Jung, I.-S. Lee, H. S. Kim, and D. G. Lee. 2006. Antimicrobial effect of furaneol against human pathogenic bacteria and fungi. J. Microbiol. Biotechnol. 16: 349-354 과학기술학회마을 ScienceOn |
15 | Silva, G. L., H. Chai, M. P. Gupta, N. R. Farnsworth, G. A. Cordell, J. M. Pezzuto, C. W. Beecher, and A. D. Kinghorn. 1995. Cytotoxic biflavonoids from Selaginella willdenowii. Phytochemistry 40: 129-134 DOI ScienceOn |
16 | MacKenzie, F. M., M. J. Struelens, K. J. Towner, and I. M. Gould. 2005. Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin. Microbiol. Infect. 11: 938-954 DOI ScienceOn |
17 | Weber, J. T. and P. Courvalin. 2005. An emptying quiver: Antimicrobial drugs and resistance. Emerg. Infect. Dis. 11: 791-793 PUBMED ScienceOn |
18 | Cha, D. S. and M. S. Chinnan. 2004. Biopolymer-based antimicrobial packaging: A review. Crit. Rev. Food Sci. Nutr. 44: 223-237 DOI ScienceOn |
19 | Cavalieri, S. J., J. R. Biehle, and W. E. Sanders Jr. 1995. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39: 1542-1545 PUBMED ScienceOn |
20 | Rice, L. B. 2006. Antimicrobial resistance in Gram-positive bacteria. Am. J. Infect. Control 34(5 Suppl 1): S11-S19 DOI PUBMED ScienceOn |
21 | Kuzin, A. P., H. Liu, J. A. Kelly, and J. R. Knox. 1995. Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillinbinding protein and in extended-spectrum beta-lactamases. Biochemistry 34: 9532-9540 DOI PUBMED |
22 | Howard, D. H., R. D. Scott, R. Packard, and D. Jones. 2003. The global impact of drug resistance. Clin. Infect. Dis. 36 (Suppl 1): S4-S10 DOI |
23 | Bush, K. 2004. Antibacterial drug discovery in the 21st century. Clin. Microbiol. Infect. 10 Suppl 4: 10-17 DOI |
24 | Lee, J. H., H. Y. Yang, H. S. Lee, and S. K. Hong. 2008. Chemical composition and antimicrobial activity of essential oil from cones of Pinus koraiensis. J. Microbiol. Biotechnol. 18: 497-502 과학기술학회마을 PUBMED |
25 | Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth Informational Supplement, Approved standard MS 100-S15. CLSI, Wayne, PA |
26 | Park, K. H., J. S. Kim, Y. R. Lee, Y. J. Moon, H. Hur, Y. H. Choi, et al. 2007. Low-density lipoprotein protects Vibrio vulnificus-induced lethality through blocking lipopolysaccharide action. Exp. Mol. Med. 39: 673-678 DOI ScienceOn |